A pilot study of serum selenium, Vitamin D, and thyrotropin concentrations in patients with thyroid cancer

Thyroid

Volumn 23, Issue 9, 2013, Pages 1079-1086

  Jonklaas, Jacqueline ^a   Danielsen, Mark ^a   Wang, Hong ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; LIOTHYRONINE; SELENIUM; THYROTROPIN; VITAMIN D; 25-HYDROXYVITAMIN D; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; DISTANT METASTASIS; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TRACE METAL BLOOD LEVEL; UNITED STATES; VITAMIN BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BLOOD; CROSS-SECTIONAL STUDY; DEFICIENCY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; THYROID NEOPLASMS; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROSPECTIVE STUDIES; SELENIUM; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; VITAMIN D;

EID: 84884164001     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0548     Document Type: Article

References (50)

1. Panel on Dietary Antioxidants and Related Compounds 2000 Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press.
2. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC 2002 Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630-639.
3. Alegria A, Barbera R, Clemente G, Farre R, Garcia MJ, Lagarda MJ 1996 Selenium and glutathione peroxidase reference values in whole blood and plasma of a reference population living in Valencia, Spain. J Trace Elem Med Biol 10:223-228.
4. Alfthan G, Neve J 1996 Reference values for serum selenium in various areas-evaluated according to the TRACY protocol. J Trace Elem Med Biol 10:77-87.
5. Niskar AS, Paschal DC, Kieszak SM, Flegal KM, Bowman B, Gunter EW, Pirkle JL, Rubin C, Sampson EJ, McGeehin M 2003 Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. Biol Trace Elem Res 91:1-10.
6. Bleys J, Navas-Acien A, Guallar E 2008 Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 168:404-410.
7. Muntau AC, Streiter M, Kappler M, Roschinger W, Schmid I, Rehnert A, Schramel P, Roscher AA 2002 Age-related reference values for serum selenium concentrations in infants and children. Clin Chem 48:555-560.
8. Ha EJ, Smith AM 2003 Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. JAmColl Nutr 22:43-51.
9. Grandjean P, Nielsen GD, Jorgensen PJ, Horder M 1992 Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest 52:321-337.
10. Aaseth J, Frey H, Glattre E, Norheim G, Ringstad J, Thomassen Y 1990 Selenium concentrations in the human thyroid gland. Biol Trace Elem Res 24:147-152.
11. Kohrle J 2005 Selenium and the control of thyroid hormone metabolism. Thyroid 15:841-853.
12. Kohrle J, Jakob F, Contempre B, Dumont JE 2005 Selenium, the thyroid, and the endocrine system. Endocr Rev 26:944-984.
13. Duntas LH 2008 Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4:454-460.
14. Duntas LH 2006 The role of selenium in thyroid autoimmunity and cancer. Thyroid 16:455-460.
15. Duntas LH 2010 Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 95:5180-5188.
16. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S 2002 Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res 88:25-30.
17. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S 2003 Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Elem Res 93:9-18.
18. Bellisola G, Bratter P, Cinque G, Francia G, Galassini S, Gawlik D, Negretti de Bratter VE, Azzolina L 1998 The TSHdependent variation of the essential elements iodine, selenium and zinc within human thyroid tissues. J Trace Elem Med Biol 12:177-182.
19. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H 1995 Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 103:85-88.
20. Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J 1989 Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 18:45-49.
21. Haug A, Graham RD, Christophersen OA, Lyons GH 2007 How to use the world's scarce selenium resources efficiently to increase the selenium concentration in food. Microb Ecol Health Dis 19:209-228.
22. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL 2012 Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response metaanalysis. J Clin Endocrinol Metab 97:2682-2692.
23. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301.
24. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814.
25. Jonklaas J, Nsouli-Maktabi H, Soldin SJ 2008 Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18:943-952.
26. Kim SS, Lee BJ, Lee JC, Song SH, Kim BH, Son SM, Kim IJ, Kim YK, Kang YH 2011 Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 39:259-265.
27. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti P, Grasso L, Elisei R, et al. 2009 Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 16:1251-1260.
28. Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W 2010 The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol 2010:805716.
29. Roskies M, Dolev Y, Caglar D, Hier MP, Mlynarek A, Majdan A, Payne RJ 2012 Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg 41:160-163.
30. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, et al. 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021.
31. Wong R, Bresee C, Braunstein G 2012 Comparison with published systems of a new staging system for papillary and follicular thyroid carcinomas. Thyroid 23:566-574, 2013.
32. Schoenfeld D 1980 Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys 6:371-374.
33. Koch GG, Gansky SA 1996 Statistical considerations for multiplicity in confirmatory protocols. Drug Inf J 30:523-533.
34. Glattre E, Nygard JF, Aaseth J 2012 Selenium and cancer prevention: observations and complexity. J Trace Elem Med Biol 26:168-169.
35. Kato MA, Finley DJ, Lubitz CC, Zhu B, Moo TA, Loeven MR, Ricci JA, Zarnegar R, Katdare M, Fahey TJ 3rd 2010 Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer 62:66-73.
36. Ganther HE 1999 Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20:1657-1666.
37. Rayman MP 2012 Selenium and human health. Lancet 379:1256-1268.
38. Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M 2011 Selenium for preventing cancer. Cochrane Database Syst Rev CD005195.
39. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. 1996 Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
40. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, et al. 2012 Selenium and prostate cancer: systematic review and metaanalysis. Am J Clin Nutr 96:111-122.
41. Fritz H, Kennedy D, Fergusson D, Fernandes R, Cooley K, Seely A, Sagar S, Wong R, Seely D 2011 Selenium and lung cancer: a systematic review and meta analysis. PLoS One 6:e26259.
42. Stepien T, Krupinski R, Sopinski J, Kuzdak K, Komorowski J, Lawnicka H, Stepien, H 2010 Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res 41:190-194.
43. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693.
44. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM, Berrington de Gonzalez A 2011 Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20:464-472.
45. Almquist M, Johansen D, Bjorge T, Ulmer H, Lindkvist BStocks T, Hallmans G, Engeland A, Rapp K, Jonsson H, et al. 2011 Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 22:743-751.
46. Leitzmann MF, Brenner A, Moore SC, Koebnick C, Park Y, Hollenbeck A, Schatzkin A, Ron E 2010 Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer 126:2947-2956.
47. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC 2002 Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94:1301-1311.
48. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA 2011 Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155:827-838.
49. McLeod DS, Cooper DS, Ladenson PW, Ain KB, Bigos ST, Brierley JD, Fein HG, Haugen BR, Jonklaas J, Magner J, et al. 2012 Prognosis of differentiated thyroid cancer in relation to at-diagnosis TSH and thyroglobulin antibody status. 82nd Annual Meeting of the American Thyroid Association, Quebec.
50. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H 2007 The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92:1263-1268.